MedPath

Safety study of endoscopic intragastric balloon placement for obese patients with endocrine and metabolic diseases

Not Applicable
Recruiting
Conditions
Obese patients with any of the metabolic disorders (diabetes, hypertension, dyslipidemia are diagnosed according to the diagnostic criteria of the Japan Diabetes Society, The Japanese Society of Internal Medicine, Japanese Atherosclerotic Disease Prevention Guidelines)
Registration Number
JPRN-UMIN000040991
Lead Sponsor
Kanazawa university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

N/A

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety of endoscopic intragastric balloon placement
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath